Advertisement
Screener

Sage Therapeutics, Inc. Revenue

Sage Therapeutics, Inc. Revenue

Sage Therapeutics, Inc. reported Revenue of $31.66 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.

Financial Statements › Income Statement

us-gaap:Revenues · last filed 2025-07-30

  • Sage Therapeutics, Inc. revenues for the quarter ending 2025-06-30 was $31.66M, a 265.84% increase year-over-year.
  • Sage Therapeutics, Inc. revenues for the quarter ending 2025-03-31 was $14.06M, a 77.97% increase year-over-year.
  • Sage Therapeutics, Inc. revenues for the quarter ending 2024-12-31 was $12.82M, a 83.56% decline year-over-year.
  • Sage Therapeutics, Inc. revenues for the quarter ending 2024-09-30 was $11.87M, a 337.08% increase year-over-year.
  • Sage Therapeutics, Inc. revenues for fiscal 2024 was $41.24M, a 52.30% decline from fiscal 2023.
  • Sage Therapeutics, Inc. revenues for fiscal 2023 was $86.45M, a 1024.84% increase from fiscal 2022.
  • Sage Therapeutics, Inc. revenues for fiscal 2022 was $7.69M, a 21.85% increase from fiscal 2021.
  • Sage Therapeutics, Inc. revenues for fiscal 2021 was $6.31M, a 99.43% decline from fiscal 2020.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2025-06-30$31.66M
10-Q · filed 2025-07-30
$45.72M
10-Q · filed 2025-07-30
$58.54M
derived: sum of 3 quarters · filed 2025-07-30
$70.41M
derived: sum of 4 quarters · filed 2025-07-30
2025-03-31$14.06M
10-Q · filed 2025-04-29
$26.88M
derived: sum of 2 quarters · filed 2025-04-29
$38.75M
derived: sum of 3 quarters · filed 2025-04-29
$47.40M
derived: sum of 4 quarters · filed 2025-07-30
2024-12-31$12.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
$24.69M
derived: sum of 2 quarters · filed 2025-02-11
$33.34M
derived: sum of 3 quarters · filed 2025-07-30
$41.24M
10-K · filed 2025-02-11
2024-09-30$11.87M
10-Q · filed 2024-10-29
$20.52M
derived: sum of 2 quarters · filed 2025-07-30
$28.43M
10-Q · filed 2024-10-29
$106.40M
derived: sum of 4 quarters · filed 2025-07-30
2024-06-30$8.65M
10-Q · filed 2025-07-30
$16.56M
10-Q · filed 2025-07-30
$94.53M
derived: sum of 3 quarters · filed 2025-07-30
$97.24M
derived: sum of 4 quarters · filed 2025-07-30
2024-03-31$7.90M
10-Q · filed 2025-04-29
$85.87M
derived: sum of 2 quarters · filed 2025-04-29
$88.59M
derived: sum of 3 quarters · filed 2025-04-29
$91.06M
derived: sum of 4 quarters · filed 2025-04-29
2023-12-31$77.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
$80.69M
derived: sum of 2 quarters · filed 2025-02-11
$83.16M
derived: sum of 3 quarters · filed 2025-02-11
$86.45M
10-K · filed 2025-02-11
2023-09-30$2.72M
10-Q · filed 2024-10-29
$5.19M
derived: sum of 2 quarters · filed 2024-10-29
$8.48M
10-Q · filed 2024-10-29
$11.35M
derived: sum of 4 quarters · filed 2025-02-11
2023-06-30$2.47M
10-Q · filed 2024-07-31
$5.77M
10-Q · filed 2024-07-31
$8.63M
derived: sum of 3 quarters · filed 2025-02-11
$10.37M
derived: sum of 4 quarters · filed 2025-02-11
2023-03-31$3.29M
10-Q · filed 2024-04-25
$6.16M
derived: sum of 2 quarters · filed 2025-02-11
$7.90M
derived: sum of 3 quarters · filed 2025-02-11
$9.40M
derived: sum of 4 quarters · filed 2025-02-11
2022-12-31$2.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
$4.60M
derived: sum of 2 quarters · filed 2025-02-11
$6.11M
derived: sum of 3 quarters · filed 2025-02-11
$7.69M
10-K · filed 2025-02-11
2022-09-30$1.74M
10-Q · filed 2023-11-07
$3.24M
derived: sum of 2 quarters · filed 2023-11-07
$4.82M
10-Q · filed 2023-11-07
$6.46M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$1.50M
10-Q · filed 2023-08-07
$3.08M
10-Q · filed 2023-08-07
$4.72M
derived: sum of 3 quarters · filed 2024-02-14
$6.17M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$1.58M
10-Q · filed 2022-05-03
$3.22M
derived: sum of 2 quarters · filed 2024-02-14
$4.66M
derived: sum of 3 quarters · filed 2024-02-14
$6.31M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$3.08M
derived: sum of 2 quarters · filed 2024-02-14
$4.72M
derived: sum of 3 quarters · filed 2024-02-14
$6.31M
10-K · filed 2024-02-14
2021-09-30$1.44M
10-Q · filed 2022-11-08
$3.08M
derived: sum of 2 quarters · filed 2022-11-08
$4.67M
10-Q · filed 2022-11-08
$1.11B
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$1.64M
10-Q · filed 2022-08-02
$3.23M
10-Q · filed 2022-08-02
$1.11B
derived: sum of 3 quarters · filed 2022-08-02
$1.11B
derived: sum of 4 quarters · filed 2022-08-02
2021-03-31$1.58M
10-Q · filed 2022-05-03
$1.11B
derived: sum of 2 quarters · filed 2022-05-03
$1.11B
derived: sum of 3 quarters · filed 2022-05-03
$1.11B
derived: sum of 4 quarters · filed 2022-05-03
2020-12-31$1.11B
10-K · filed 2021-02-24
$1.11B
derived: sum of 2 quarters · filed 2021-11-02
$1.11B
derived: sum of 3 quarters · filed 2021-11-02
$1.11B
10-K · filed 2023-02-16
2020-09-30$1.64M
10-Q · filed 2021-11-02
$2.73M
derived: sum of 2 quarters · filed 2021-11-02
$5.01M
10-Q · filed 2021-11-02
$6.97M
derived: sum of 4 quarters · filed 2021-11-02
2020-06-30$1.09M
10-Q · filed 2021-08-03
$3.38M
10-Q · filed 2021-08-03
$5.33M
derived: sum of 3 quarters · filed 2021-08-03
$8.90M
derived: sum of 4 quarters · filed 2021-08-03
2020-03-31$2.29M
10-K · filed 2021-02-24
$4.25M
derived: sum of 2 quarters · filed 2021-02-24
$7.82M
derived: sum of 3 quarters · filed 2021-02-24
$8.69M
derived: sum of 4 quarters · filed 2021-02-24
2019-12-31$1.96M
10-K · filed 2021-02-24
$5.53M
derived: sum of 2 quarters · filed 2021-02-24
$6.40M
derived: sum of 3 quarters · filed 2021-02-24
$6.87M
10-K · filed 2022-02-24
2019-09-30$3.57M
10-K · filed 2021-02-24
$4.44M
derived: sum of 2 quarters · filed 2021-02-24
$4.91M
10-Q · filed 2020-11-05
$5.18M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$873.00K
10-K · filed 2021-02-24
$1.34M
10-Q · filed 2020-08-10
$1.61M
derived: sum of 3 quarters · filed 2021-02-24
$1.61M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$465.00K
10-K · filed 2021-02-24
$738.00K
derived: sum of 2 quarters · filed 2021-02-24
$738.00K
derived: sum of 3 quarters · filed 2021-02-24
$90.74M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$273.00K
10-K · filed 2020-02-27
$273.00K
derived: sum of 2 quarters · filed 2020-02-27
$90.27M
derived: sum of 3 quarters · filed 2020-02-27
$90.27M
10-K · filed 2021-02-24
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$90.00M
derived: sum of 2 quarters · filed 2020-02-27
$90.00M
10-Q · filed 2019-11-12
2018-06-30$90.00M
10-K · filed 2020-02-27
$90.00M
10-Q · filed 2019-08-06